Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic and orthopedic industries.
The 2020 edition of Market Scope’s "Premium Cataract Surgery Market Report" is designed to provide insight into the most important premium cataract surgery (PCS) markets in the world. We’ve selected and profiled 13 countries that collectively account for 82.7 percent of global PCS revenue and provided a deep dive into each of these markets. Ranked by PCS market size, they are: the US, Japan, Germany, France, Italy, Spain, the UK, Canada, Australia, South Korea, China, India, and Brazil.
It is our perception that companies planning to market premium cataract surgery devices often have only a general understanding of the size and characteristics of these key country markets. For each of these countries, we focus on specific characteristics considered vital to the understanding of the PCS opportunities there.
The report forecasts manufacturer and provider revenues for 2019 through 2025 for toric IOLs, PC-IOLs, intermediate-optimized IOLs, adjustable IOLs, FLACS, FLACS LRI, manual LRI, and excimer IOL enhancements. It also includes a summary of PCS market drivers such as technology advancements, public PCS awareness, reimbursement policies, and population wealth.
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.